Once more we are back to the implantable chips and everyone kind of remembers when the company came out with the implantable chip that holds personal health records. Positive ID has been on a little different mission of late, still implantable but different applications. You can read below on what they are working on with Siemens. The idea of the implanted chip in some form or another has not died off yet.
PositiveID The “Chip” People are Back-an Agreement with Siemens To Expand Wireless Body Monitoring With A Chip Implant
The Gluco-Chip is patented now and will be able to measure glucose levels in your body. An FDA 501k application has been submitted to the FDA for approval and you can read more about it here.
When you visit the website, wouldn’t you know this is being marketed toward insurance companies too? The data transmission is set to be HIPAA compliant but we still don’t know what part of the data might just be for sale and with the insurer marketing end of it, don’t count this short with privacy issues and anonimized data for sale, after all Walgreens as an example says their “data selling” business is worth just under $800 million.
Here’s how the reporting looks, you can have your glucose in a pie chart, have a trend report, etc. like like we all look at with business reports, so you glucose is becoming a “business” with similar reporting algorithms. I just wonder does the normal consumer want this? Does their doctor have time for the data to analyze? I just think devices like this are better off going to a consumer PHR like HealthVault and cut the data sales out or tax it. Taxing the sale of data could bring some new funding in for hospitals and other areas of healthcare where big business has choked their budgets. If you are not aware of this, read the news with hospitals and doctors with compensation dwindling and insurers driving this with contracts while they derive bigger profits. BD
Monday, June 13, 2011
Privacy Wanted–So Let’s Require Those Who Sell Web Data to Register and Tax the Transactions and Publicly Disclose Who They Sell To With a Federal Registry
PositiveID, a developer of medical devices for diabetes management, biological detection systems and clinical diagnostics, has developed a continuous glucose sensing system.
The system has a glucose sensor, which is an important component of PositiveID’s GlucoChip, a glucose-sensing implantable RFID microchip. The chip has the capability to precisely measure glucose levels in diabetes patients.
PositiveID has successfully laboratory-tested the closed-cycle glucose sensing system, which is stable and reproducible. The company has collaborated with Receptors to create the glucose sensing system based on Receptors’ proprietary chemistry platform. Synthetic materials, which were specifically designed, were used for the glucose sensing system. The GlucoChip technology is based on PositiveID’s VeriChip, a microchip designed for patient identification, and the company’s "Embedded Bio-Sensor System" patent. The 7,125,382 patent covers a remote transponder that wirelessly communicates with a passively-powered implantable on-chip transponder and a bio-sensor system that utilizes the RFID technology.